Award notice Supplies

suministro de los principios activos denominados "EPOETINA BETA PEGILADA " para el Hospital Universitario de Gran Canaria Dr.Negrín.

Notice published in Spanish. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria
Place of performance: Las Palmas de Gran Canaria
Estimated value: €305,674 excl. VAT
Amount awarded: €305,648 excl. VAT
Bids received: 1
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 13 July 2026
Notice language: Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

El objeto del contrato viene determinado por el suministro de los principios activos denominados "EPOETINA BETA PEGILADA" para elHospital Universitario de Gran Canaria Dr. Negrín.Dicho objeto corresponde al código 33690000-3 (Medicamentos diversos), de la nomenclatura Vocabulario Común de Contratos (CPV) dela Comisión Europea.

Awarded to

ROCHE FARMA, S.A.

8 lots

Epoetina beta 30 MCG/0,3 ML
Epoetina beta 50 MCG/0,3 ML
Epoetina beta 75 MCG/0,3 ML
Epoetina beta 100 MCG/0,3 ML
Epoetina beta 120 MCG/0,3 ML
Epoetina beta 150 MCG/0,3 ML
Epoetina beta 200 MCG/0,3 ML
Epoetina beta 250 MCG/0,3 ML

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33690000

Winning prices for comparable contracts

A quarter below: €187,264
Median: €427,798
A quarter above: €1,055,147

Amounts awarded (excl. VAT) over the last 3 years for 161 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Suministro de medicamentos toxina botulínica (DOE) tipo A Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 2 October 2026	IPSEN PHARMA, S.A.U. Merz Therapeutics Iberia S.L. ABBVIE SPAIN, S.L.U.	€290,141
Suministro del principio activo denominado "TILDRAKIZUMAB 100 MG JERINGA SC" para el Hospital Universitario de Gran Canaria Dr.Negrín. Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 29 September 2026	Almirall, S.A.	€475,960
Suministro del principio activo denominado "GELATINA 4% 40MG/MLEN SOL BALANCEADA 500ML" para el Hospital Universitario de Gran Canaria Dr. Negrín. Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 22 September 2026	B.Braun Medical, S.A.	€48,720
suministro del principio activo denominado " AVAPRITINIB 100 MGCOMPRIMIDO ORAL " para el Hospital Universitario de Gran Canaria Dr. Negrín. Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 18 September 2026	BLUEPRINT MEDICINES (NETHERLANDS)	€83,973
suministro de los principios activos denominados "DRONABINOL + CANNABIDIOL y "LEBRIKIZUMAB250 MG" para el Hospital Universitario de Gran Canaria Dr. Negrín. Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 17 September 2026	ALMIRALL, S.A	€154,090

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 482701-2026.